173 related articles for article (PubMed ID: 2283813)
21. IgM anti-HD in acute hepatitis D: diagnostic and prognostic significance.
Aragona M; Macagno S; Caredda F; Crivelli O; Lavarini C; Bertolusso L; Farci P; Rizzetto M
Prog Clin Biol Res; 1987; 234():243-8. PubMed ID: 3628379
[No Abstract] [Full Text] [Related]
22. [Influence of HDV infection on the course of HBsAg-positive chronic hepatitis in a pediatric case series].
Calzia R; Ciravegna B; Marazzi MG; Navone C; Piscopo R; Facco F
Minerva Pediatr; 1986 Jun; 38(11-12):451-6. PubMed ID: 3526109
[No Abstract] [Full Text] [Related]
23. Anti-delta antibody in various HBsAg positive Argentine populations.
Fay O; Tanno H; Palazzi J; Gatti H
Prog Clin Biol Res; 1987; 234():517-8. PubMed ID: 3628422
[No Abstract] [Full Text] [Related]
24. Prevalence of wildtype and pre-C HBV variants in HBsAg/anti-HBe positive carriers with chronic hepatitis delta virus infection.
Santantonio T; Jung MC; Monno L; Milella M; Iacovazzi T; Pastore G; Will H
Prog Clin Biol Res; 1993; 382():235-42. PubMed ID: 8502687
[No Abstract] [Full Text] [Related]
25. Dynamics of serum markers in the different course of hepatitis B virus (HBV) infection.
Stancek D; Blaskovicová H; Hajnická V; Husár K; Holenová Z; Mathernová V; Sudová J; Laktis K; Spanárová V
Acta Virol; 1987 May; 31(3):234-42. PubMed ID: 2888287
[TBL] [Abstract][Full Text] [Related]
26. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
27. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
Stroun J; Peitrequin R; Frei PC
Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia.
Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H
J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981
[TBL] [Abstract][Full Text] [Related]
29. Serologic markers of hepatitis B virus (HBV) and hepatitis D virus infection in carriers of hepatitis B surface antigen who are frequently exposed to HBV.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayiannis A; Sjogren MH; Engle R; Karpodini E; Purcell RH
Hepatogastroenterology; 1986 Aug; 33(4):151-4. PubMed ID: 3758906
[TBL] [Abstract][Full Text] [Related]
30. [Frequency and clinical relevance of delta virus infection in HBsAg carriers in the Berlin area].
Möller B; Hopf U; Hoffmann H; Alexander M; Lobeck H
Z Gastroenterol; 1988 Jun; 26(6):314-21. PubMed ID: 3264646
[TBL] [Abstract][Full Text] [Related]
31. Incidence of hepatitis delta virus infection in acute HBsAg-negative hepatitis.
Caredda F; Antinori S; Pastecchia C; Coppin P; Palla M; Ponzetto A; Rizzetto M; Moroni M
J Infect Dis; 1989 May; 159(5):977-9. PubMed ID: 2496175
[No Abstract] [Full Text] [Related]
32. Endemic hepatitis delta virus infection in a Greek community.
Hadziyannis SJ; Hatzakis A; Papaioannou C; Anastassakos C; Vassiliadis E
Prog Clin Biol Res; 1987; 234():181-202. PubMed ID: 2442775
[No Abstract] [Full Text] [Related]
33. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
[TBL] [Abstract][Full Text] [Related]
34. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan.
Lu SN; Chen TM; Lee CM; Wang JH; Tung HD; Wu JC
J Med Virol; 2003 May; 70(1):74-80. PubMed ID: 12629646
[TBL] [Abstract][Full Text] [Related]
35. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference.
Jardi R; Rodriguez F; Buti M; Costa X; Cotrina M; Galimany R; Esteban R; Guardia J
Hepatology; 2001 Aug; 34(2):404-10. PubMed ID: 11481626
[TBL] [Abstract][Full Text] [Related]
36. Frequency and comparative analysis of hapatitis D in petients seeking treatment for hepatitis B.
Zuberi BF; Quraishy MS; Afsar S; Kazi LA; Memon AR; Qadeer R; Kumar A; Akhtar N
J Coll Physicians Surg Pak; 2006 Sep; 16(9):581-4. PubMed ID: 16945230
[TBL] [Abstract][Full Text] [Related]
37. [Highly sensitive methods for the serological,diagnosis of hepatitis B and their clinico-epidemiological significance].
Botsvadze ESh; Aleksishvili MM; Gegeshidze TN; Mosakhlishvili NG
Ter Arkh; 1990; 62(2):79-82. PubMed ID: 2336630
[TBL] [Abstract][Full Text] [Related]
38. Fulminant hepatitis in asymptomatic hepatitis B surface antigen carriers in Greece.
Tassopoulos NC; Papaevangelou GJ; Roumeliotou-Karayannis A; Smedile A; Engle R; Ticehurst JR; Feinstone SM; Purcell RH
J Med Virol; 1986 Dec; 20(4):371-9. PubMed ID: 3098915
[TBL] [Abstract][Full Text] [Related]
39. [Changes in the response time of anti-HBc IgM in a hepatitis B case load. Diagnostic implications].
Cremoni L; Buffa D; Sauco F; Bongetta R; Arosio M; d'Amico P
Boll Ist Sieroter Milan; 1986; 65(5):430-5. PubMed ID: 3828097
[TBL] [Abstract][Full Text] [Related]
40. Seroepidemiology of hepatitis D (delta agent) and hepatitis B among Virginia State prisoners.
Tucker RM; Gaffey MJ; Fisch MJ; Kaiser DL; Guerrant RL; Normansell DE
Clin Ther; 1987; 9(6):622-8. PubMed ID: 3440274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
